Because Dexilant is protected by patents, no generic version of this medication is available at this time. The first patent is set to expire in December 2020, which is the earliest predictable date that a generic Dexilant may be manufactured. It's important to note that dexlansoprazole is the "generic name" for this product; it is not a "generic version."
Dexilant™ (dexlansoprazole) is a prescription medication approved for treating heartburn due to gastroesophageal reflux disease (GERD) and erosive esophagitis (a severe form of GERD). Dexilant is part of a group of medications known as proton pump inhibitors, or PPIs for short.
Dexilant is made by Takeda Pharmaceuticals America, Inc. Currently, the drug is protected by patents that prevent any generic versions from being sold in the United States.
The first patent for Dexilant currently expires in December 2020. This is the earliest predictable date that a generic version of the drug could become available. However, this could change, depending on many factors such as lawsuits or additional patents. Once Dexilant goes off-patent, there may be several companies that will manufacture a generic Dexilant drug.
No -- dexlansoprazole is the active ingredient in Dexilant, but is not a generic version of it. What can be confusing is that oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different from a generic version of a medicine.
In order for there to be a generic version of a medicine, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.